Severe Congestion And Cough Tablet, Film Coated
NDC Package 59779-648-01
Package Information
Severe Congestion And Cough (dextromethorphan hbr, guaifenesin, phenylephrine hcl) tablets is do not take more than 12 caplets in any 24-hour periodadults and children 12 years and over: take 2 caplets every 4 hourschildren under 12 years: do not useĀ . This formulation utilizes a tablet, film coated delivery system. Marketed by Cvs Pharmacy, this product is identified by NDC 59779-648 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1372652 - dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
- RxCUI: 1372652 - dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI: 1372652 - dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 59779 - Cvs Pharmacy
- 59779-648 - Severe Congestion And Cough
- 59779-648-01 - 3 BLISTER PACK in 1 PACKAGE / 10 TABLET, FILM COATED in 1 BLISTER PACK
- 59779-648 - Severe Congestion And Cough
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (59779-648). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59779-648-01 identifies a specific commercial package of 3 blister pack in 1 package / 10 tablet, film coated in 1 blister pack of Severe Congestion And Cough Multi-symptom Maximum Strength, a human over the counter drug labeled by Cvs Pharmacy. This product is billed for "EA" each discreet unit and contains an estimated amount of 3 billable units per package. This tablet, film coated is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cvs Pharmacy on July 20, 2015. The current certification is valid through December 31, 2026.
How is this Cvs Pharmacy product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59779064801. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 3 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.